Search research articles
Contact Us
Filters
Showing results (81-90 of 97) with videos related to
Page
of 10
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 28, 2015
Feasibility of in situ, high-resolution correlation of tracer uptake with histopathology by quantitative autoradiography of biopsy specimens obtained under 18F-FDG PET/CT guidance
Louise M Fanchon, Snjezana Dogan, Andre L Moreira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2021
Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma
Kyrollis Attalla, Renzo G DiNatale, Phillip M Rappold, et al.
Radiology
|
November 28, 2018
Autologous Blood Patch Injection versus Hydrogel Plug in CT-guided Lung Biopsy: A Prospective Randomized Trial
Majid Maybody, Nadim Muallem, Karen T Brown, et al.
The Lancet. Oncology
|
June 17, 2022
MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study
Behfar Ehdaie, Clare M Tempany, Ford Holland, et al.
Cancer Immunology Research
|
September 3, 2016
Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy
David B Page, Jianda Yuan, David Redmond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 7, 2022
The Impact of PIK3R1 Mutations and Insulin-PI3K-Glycolytic Pathway Regulation in Prostate Cancer
Goutam Chakraborty, Subhiksha Nandakumar, Rahim Hirani, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 22, 2014
⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
Neeta Pandit-Taskar, Joseph A O'Donoghue, Volkan Beylergil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 16, 2015
A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer
Neeta Pandit-Taskar, Joseph A O'Donoghue, Jeremy C Durack, et al.
European Urology Focus
|
October 26, 2017
Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma
Maria F Becerra, Ed Reznik, Almedina Redzematovic, et al.
European Urology Focus
|
July 30, 2017
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples
Yiyu Dong, Brandon J Manley, Maria F Becerra, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 97) with videos related to
Sort By:
Page
of 10
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 28, 2015
Feasibility of in situ, high-resolution correlation of tracer uptake with histopathology by quantitative autoradiography of biopsy specimens obtained under 18F-FDG PET/CT guidance
Louise M Fanchon, Snjezana Dogan, Andre L Moreira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2021
Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma
Kyrollis Attalla, Renzo G DiNatale, Phillip M Rappold, et al.
Radiology
|
November 28, 2018
Autologous Blood Patch Injection versus Hydrogel Plug in CT-guided Lung Biopsy: A Prospective Randomized Trial
Majid Maybody, Nadim Muallem, Karen T Brown, et al.
The Lancet. Oncology
|
June 17, 2022
MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study
Behfar Ehdaie, Clare M Tempany, Ford Holland, et al.
Cancer Immunology Research
|
September 3, 2016
Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy
David B Page, Jianda Yuan, David Redmond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 7, 2022
The Impact of PIK3R1 Mutations and Insulin-PI3K-Glycolytic Pathway Regulation in Prostate Cancer
Goutam Chakraborty, Subhiksha Nandakumar, Rahim Hirani, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 22, 2014
⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
Neeta Pandit-Taskar, Joseph A O'Donoghue, Volkan Beylergil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 16, 2015
A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer
Neeta Pandit-Taskar, Joseph A O'Donoghue, Jeremy C Durack, et al.
European Urology Focus
|
October 26, 2017
Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma
Maria F Becerra, Ed Reznik, Almedina Redzematovic, et al.
European Urology Focus
|
July 30, 2017
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples
Yiyu Dong, Brandon J Manley, Maria F Becerra, et al.
Page
of 10